The Efficacy and Safety of iGlarLixi in Insulin-Naive Adults with Type 2 Diabetes (T2D) by Baseline Age, Sodium-Glucose Cotransporter 2 Inhibitor (SGLT2i) Use, and BMI-Post Hoc Analysis of Soli-CGM

Viral N. Shah; Alexandria Ratzki-Leewing; Hemant Thacker; Abdullah Alguwaihes; Selcuk Dagdelen; Agustina Alvarez; Felipe Lauand; Alice Y. Cheng

doi:10.2337/db25-24-PUB

The Efficacy and Safety of iGlarLixi in Insulin-Naive Adults with Type 2 Diabetes (T2D) by Baseline Age, Sodium-Glucose Cotransporter 2 Inhibitor (SGLT2i) Use, and BMI-Post Hoc Analysis of Soli-CGM

Viral N. Shah
, Alexandria Ratzki-Leewing
, Hemant Thacker
, Abdullah Alguwaihes
, Selcuk Dagdelen
, Agustina Alvarez
, Felipe Lauand
, Alice Y. Cheng

Division of Internal Medicine (Medicine)

Research output: Contribution to journal › Meeting Abstract › peer-review

Original language	English
Number of pages	2
Journal	Diabetes
Volume	74
DOIs	https://doi.org/10.2337/db25-24-PUB
Publication status	Published - Jun 2025
Event	85th Scientific Sessions of the American-Diabetes-Association (ADA) - Chicago, Israel Duration: 20 Jun 2025 → 23 Jun 2025

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.2337/db25-24-PUB

Cite this

Shah, V. N., Ratzki-Leewing, A., Thacker, H., Alguwaihes, A., Dagdelen, S., Alvarez, A., Lauand, F., & Cheng, A. Y. (2025). The Efficacy and Safety of iGlarLixi in Insulin-Naive Adults with Type 2 Diabetes (T2D) by Baseline Age, Sodium-Glucose Cotransporter 2 Inhibitor (SGLT2i) Use, and BMI-Post Hoc Analysis of Soli-CGM. Diabetes, 74. https://doi.org/10.2337/db25-24-PUB

@article{40bb1be156d44df8bd9a7a1ea5382fb7,

title = "The Efficacy and Safety of iGlarLixi in Insulin-Naive Adults with Type 2 Diabetes (T2D) by Baseline Age, Sodium-Glucose Cotransporter 2 Inhibitor (SGLT2i) Use, and BMI-Post Hoc Analysis of Soli-CGM",

author = "Shah, \{Viral N.\} and Alexandria Ratzki-Leewing and Hemant Thacker and Abdullah Alguwaihes and Selcuk Dagdelen and Agustina Alvarez and Felipe Lauand and Cheng, \{Alice Y.\}",

year = "2025",

month = jun,

doi = "10.2337/db25-24-PUB",

language = "English",

volume = "74",

journal = "Diabetes",

issn = "0012-1797",

publisher = "American Diabetes Association Inc.",

note = "85th Scientific Sessions of the American-Diabetes-Association (ADA) ; Conference date: 20-06-2025 Through 23-06-2025",

}

The Efficacy and Safety of iGlarLixi in Insulin-Naive Adults with Type 2 Diabetes (T2D) by Baseline Age, Sodium-Glucose Cotransporter 2 Inhibitor (SGLT2i) Use, and BMI-Post Hoc Analysis of Soli-CGM. / Shah, Viral N.; Ratzki-Leewing, Alexandria; Thacker, Hemant et al.
In: Diabetes, Vol. 74, 06.2025.

Research output: Contribution to journal › Meeting Abstract › peer-review

TY - JOUR

T1 - The Efficacy and Safety of iGlarLixi in Insulin-Naive Adults with Type 2 Diabetes (T2D) by Baseline Age, Sodium-Glucose Cotransporter 2 Inhibitor (SGLT2i) Use, and BMI-Post Hoc Analysis of Soli-CGM

AU - Shah, Viral N.

AU - Ratzki-Leewing, Alexandria

AU - Thacker, Hemant

AU - Alguwaihes, Abdullah

AU - Dagdelen, Selcuk

AU - Alvarez, Agustina

AU - Lauand, Felipe

AU - Cheng, Alice Y.

PY - 2025/6

Y1 - 2025/6

UR - https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=performanshacettepe&SrcAuth=WosAPI&KeyUT=WOS:001522824700047&DestLinkType=FullRecord&DestApp=WOS_CPL

U2 - 10.2337/db25-24-PUB

DO - 10.2337/db25-24-PUB

M3 - Meeting Abstract

SN - 0012-1797

VL - 74

JO - Diabetes

JF - Diabetes

T2 - 85th Scientific Sessions of the American-Diabetes-Association (ADA)

Y2 - 20 June 2025 through 23 June 2025

ER -

The Efficacy and Safety of iGlarLixi in Insulin-Naive Adults with Type 2 Diabetes (T2D) by Baseline Age, Sodium-Glucose Cotransporter 2 Inhibitor (SGLT2i) Use, and BMI-Post Hoc Analysis of Soli-CGM

UN SDGs

Access to Document

Other files and links

Cite this